Ethyl 1-(4-broMophenyl)-3-Methyl-1H-pyrazole-5-carboxylate
- $45 - $564
- Product name: Ethyl 1-(4-broMophenyl)-3-Methyl-1H-pyrazole-5-carboxylate
- CAS: 385831-39-0
- MF: C13H13BrN2O2
- MW: 309.16
- EINECS:
- MDL Number:MFCD06408987
- Synonyms:Ethyl 1-(4-broMophenyl)-3-Methyl-1H-pyrazole-5-carboxylate;1H-Pyrazole-5-carboxylic acid, 1-(4-bromophenyl)-3-methyl-, ethyl ester
4 prices
Selected condition:
Brand
- Crysdot
- TRC
Package
- 100mg
- 500mg
- 5g
- 10g
- ManufacturerCrysdot
- Product numberCD11131407
- Product descriptionEthyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate 95+%
- Packaging5g
- Price$339
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11131407
- Product descriptionEthyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate 95+%
- Packaging10g
- Price$564
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE900838
- Product descriptionEthyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate
- Packaging100mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE900838
- Product descriptionEthyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate
- Packaging500mg
- Price$115
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11131407 | Ethyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate 95+% | 5g | $339 | 2021-12-16 | Buy |
Crysdot | CD11131407 | Ethyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate 95+% | 10g | $564 | 2021-12-16 | Buy |
TRC | E900838 | Ethyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate | 100mg | $45 | 2021-12-16 | Buy |
TRC | E900838 | Ethyl1-(4-bromophenyl)-3-methyl-1H-pyrazole-5-carboxylate | 500mg | $115 | 2021-12-16 | Buy |
Properties
Boiling point :390.5±32.0 °C(Predicted)
Density :1.43±0.1 g/cm3(Predicted)
pka :-2.06±0.10(Predicted)
Density :1.43±0.1 g/cm3(Predicted)
pka :-2.06±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|